Developer of a disease-specific simulation software designed to replace animal drug testing by using artificial intelligence. The company's software helps to increase human life expectancy through intelligence-driven biosystem simulations to personalize patient treatment and uses advanced computational approaches to allow researchers to design proprietary chemical entities, compounds, and drug candidates more quickly and economically, enabling pharmaceutical scientists to improve the accuracy and efficiency of drug development and make personalized health care a reality.